Publicacións (43) Publicacións de EVA ALLONCA CAMPA

2023

  1. Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  2. The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma

    Nature Communications, Vol. 14, Núm. 1

2021

  1. SDCBP modulates stemness and chemoresistance in head and neck squamous cell carcinoma through src activation

    Cancers, Vol. 13, Núm. 19

2020

  1. Expression of E-cadherin and β-catenin in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas

    Acta Otorrinolaringologica Espanola, Vol. 71, Núm. 6, pp. 358-366

  2. GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β

    Cell Death and Disease, Vol. 11, Núm. 11

  3. Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma

    Oral Oncology, Vol. 110

  4. Lectin-like transcript 1 (LLT1) checkpoint: A novel independent prognostic factor in HPV-negative oropharyngeal squamous cell carcinoma

    Biomedicines, Vol. 8, Núm. 12, pp. 1-14

  5. PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas

    Cancer Immunology, Immunotherapy, Vol. 69, Núm. 10, pp. 2089-2100

  6. Prognostic significance of the pluripotency factors NANOG, SOX2, and OCT4 in head and neck squamous cell carcinomas

    Cancers, Vol. 12, Núm. 7, pp. 1-15

  7. Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications

    Cancers, Vol. 12, Núm. 4

  8. Tspan1: A novel protein involved in head and neck squamous cell carcinoma chemoresistance

    Cancers, Vol. 12, Núm. 11, pp. 1-20

2019

  1. Frequent alteration of annexin A9 and A10 in HPV-negative head and neck squamous cell carcinomas: Correlation with the histopathological differentiation grade

    Journal of Clinical Medicine, Vol. 8, Núm. 2

  2. PD-L1 expression in tumor cells is an independent unfavorable prognostic factor in oral squamous cell carcinoma

    Cancer Epidemiology Biomarkers and Prevention, Vol. 28, Núm. 3, pp. 546-554

  3. SOX2 expression is an independent predictor of oral cancer progression

    Journal of Clinical Medicine, Vol. 8, Núm. 10

  4. The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042

    Journal of Clinical Medicine, Vol. 8, Núm. 8

  5. The differential impact of SRC expression on the prognosis of patients with head and neck squamous cell carcinoma

    Cancers, Vol. 11, Núm. 11

  6. The emerging role of NANOG as an early cancer risk biomarker in patients with oral potentially malignant disorders

    Journal of Clinical Medicine, Vol. 8, Núm. 9

  7. The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas

    International Journal of Cancer, Vol. 145, Núm. 1, pp. 254-266

2018

  1. Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients

    Journal of Clinical Medicine, Vol. 7, Núm. 12

  2. Immunohistochemical expression of cortactin and focal adhesion kinase predicts recurrence risk and laryngeal cancer risk beyond histologic grading

    Cancer Epidemiology Biomarkers and Prevention, Vol. 27, Núm. 7, pp. 805-813